Terry Vance, Director at ENANTA PHARMACEUTICALS INC (ENTA), sold 30,590 shares at $9.12 ($279K) on 2023-12-13, disclosed to the SEC on 2023-12-15.
Open-market sale of $279k ENTA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.12 | 15,295 | $139K | 50.0% |
| 2 | $9.12 | 15,295 | $139K | 50.0% |
| Total | $9.12 avg | 30,590 | $279K | 100% |
| Filing → |